Clinical Trial Update: Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a combination of lopinavir/ritonavir, ribavirin, and interferon-beta for novel coronavirus infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Novel Coronavirus Infection

Drugs mentioned

• Interferon-beta (interferon beta)
• Lopinavir/ritonavir (lopinavir/ritonavir)
• Ribavirin (ribavirin)

Snippet

Sponsor: The University of Hong Kong | Conditions: Novel Coronavirus Infection | Phase 2 | Status: COMPLETED